SEC Tracker
Get the app

Bambusa Therapeutics BBTX

Bambusa Therapeutics filed amended corporate documents

Form
8-K
Filed
Importance
Routine
  1. Filed amended and restated certificate of incorporation on Nov 2, 2026
  2. Adopted amended and restated bylaws on Nov 2, 2026
  3. Exhibits 3.1 and 3.2 include full text of corporate documents

Written from the 8-K on EDGAR. Check the filing before you rely on it.

Open in the appGet the appView on EDGAR

Get an email when Bambusa Therapeutics files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Same SIC code (2836) and public float not reported.

  1. Adaptimmune Therapeutics ADAP
  2. Adverum Biotechnologies ADVM
  3. AgomAb Therapeutics AGMB
  4. Alvotech ALVO
  5. Argenx ARGX